"Cancer is not a monolith. "We speak about cancer like it's one disease, but it's more like thousands of different diseases," said Simone Korsgaard Jensen, CEO and founder of Radical Health. "On top of that, every single individual is so different. But right now we still treat it with a one-size fits-all approach. And that's where data and AI can especially step in to help.""
"In 2024, Jensen started Radical Health through the Entrepreneurs First accelerator program with this idea: That AI's unique ability to analyze massive quantities of data and turn around probabilistic, personalized feedback could reinvent how patients navigate the cancer treatment process. "The only way we can [search all available research and data] is using AI," Jensen told Fortune. "AI can make treatment recommendations from looking at ten million patients from the past, find the most similar patients, and reason through that.""
"Radical has just emerged from stealth, having raised $5 million in pre-seed funding led by Khosla Ventures. Vinod Khosla, Khosla Ventures founder, said via email that he was drawn to the prospect that Radical could democratize information around cancer treatment by scaling "the expertise of the best oncologists." To that end, Radical's model is built on a combination of public data and patient data drawn from partnerships with UCSF and the Mayo Clinic. The data includes imaging, radiology, pathology, genetic data, and patient records-covering more than ten million cases."
Radical Health launched in 2024 to apply AI to cancer care by analyzing massive, multimodal datasets and delivering probabilistic, personalized treatment guidance. The platform aggregates public and partnered patient data, including imaging, radiology, pathology, genetics, and records covering more than ten million cases from institutions such as UCSF and the Mayo Clinic. The company raised $5 million in pre-seed funding led by Khosla Ventures. Patients sign up, link medical records, and receive a personalized report within about an hour that recommends therapies and strategies to discuss with oncologists. The app is free and publicly available.
Read at Fortune
Unable to calculate read time
Collection
[
|
...
]